Ligand · 0YQ
0YQ · 2,2'-[(2-{[2-({[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]carbonyl}amino)ethyl]amino}-2-oxoethyl)imino]diacetic acid (non-preferred name)
0YQ, 2,2'-[(2-{[2-({[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]carbonyl}amino)ethyl]amino}-2-oxoethyl)imino]diacetic acid (non-preferred name) (C17 H23 N5 O11, 473.4 g/mol), in the MolNFT…
- Component
- 0YQ
- Formula
- C17 H23 N5 O11
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
0YQ in 2 structures; the first of them:
- 4H1Y · Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with PSB11552 · 0YQ P603 · binds ARG354, ASN390, GLY392, GLY393, ARG395, PHE417, GLY447, PHE500 and 1 more
- 4H1Y · Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with PSB11552 · 0YQ P603 · binds ARG354, ASN390, GLY392, GLY393, ARG395, PHE417, GLY447, PHE500 and 1 more
Residues it binds most
GLY 2, ARG 2, PHE 2, ASN 2, ASP 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.